Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.7602
-0.0522 (-6.43%)
At close: Sep 17, 2025, 4:00 PM EDT
0.7600
-0.0002 (-0.03%)
After-hours: Sep 17, 2025, 7:44 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $63.29 million as of September 17, 2025. Its market cap has decreased by -48.10% in one year.
Market Cap
63.29M
Enterprise Value
-46.32M
1-Year Change
-48.10%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $63.29M, a decrease of -79.02%. That is a compound annual growth rate of -26.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 67.64M | -14.68% |
| Dec 31, 2024 | 79.27M | -2.83% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |